Analyst Recommendations

1,023.72 -20.94(-2.00%)07/03/2024
Regeneron Pharmaceuticals, Inc. (REGN)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Outperform9
Buy6
Neutral5
Overweight3
Underperform1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades